Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
The introduction of pharmacoeconomic analysis in Norway - are the users prepared?
Autore:
Rorvik, EM; Toverud, EL; Walloe, L;
Indirizzi:
Univ Oslo, Sch Pharm, Dept Social Pharm, N-0316 Oslo, Norway Univ Oslo Oslo Norway N-0316 arm, Dept Social Pharm, N-0316 Oslo, Norway Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0316 Oslo, Norway Univ Oslo Oslo Norway N-0316 Med Sci, Dept Physiol, N-0316 Oslo, Norway
Titolo Testata:
PHARMACY WORLD & SCIENCE
fascicolo: 4, volume: 23, anno: 2001,
pagine: 135 - 144
SICI:
0928-1231(2001)23:4<135:TIOPAI>2.0.ZU;2-E
Fonte:
ISI
Lingua:
ENG
Soggetto:
PHARMACEUTICALS; GUIDELINES; POLICY;
Keywords:
attitudes; factor analysis; interview; knowledge; Norway; pharmaceutical industry; pharmacoeconomic analysis; public authorities;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
19
Recensione:
Indirizzi per estratti:
Indirizzo: Rorvik, EM Univ Oslo, Sch Pharm, Dept Social Pharm, N-0316 Oslo, Norway Univ Oslo Oslo Norway N-0316 ocial Pharm, N-0316 Oslo, Norway
Citazione:
E.M. Rorvik et al., "The introduction of pharmacoeconomic analysis in Norway - are the users prepared?", PHARM WORLD, 23(4), 2001, pp. 135-144

Abstract

Objective: The aim of this study was to investigate existing perceptions and knowledge of pharmacoeconomic analyses, and attitudes towards them, among personnel from the pharmaceutical authorities and the pharmaceutical industry in Norway who work with medicines in various capacities, and to investigate whether there were evident differences between the two groups. Method: Personal interviews were conducted with 33 employees from the public authorities and 46 from the pharmaceutical industry, using a semi-structured questionnaire. This focused on knowledge of and attitudes towards pharmacoeconomics. Main outcome measure: A factor analysis conducted on questions related to attitude. Results: The factor analysis showed that the employees from the public authorities were significantly more positive to the introduction and use of pharmacoeconomic analyses than those from the industry, and they were less sceptical about how well prepared or receptive the market is. In addition theinformants from both groups had a relatively good understanding of the terms most commonly used in the field of pharmacoeconomics. They were also aware of some of the costs and outcomes involved in the analyses. Conclusion:If the groups interviewed are to become more involved in actualdecision-making on the basis of pharmacoeconomic analyses, they need more training to gain the necessary in-depth knowledge, since their knowledge ofthe field was somewhat superficial.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/04/20 alle ore 02:18:59